CellAegis completed its patient enrollment in a large-scale, UK investigator-sponsored trial to further assess the efficacy of remote ischemic conditioning (RIC) in reducing clinical events in patients presenting with STEMI in patients receiving treatment in hospital catheterization labs or emergency rooms.
CellAegis Completes Patient Enrollment in Trial
Previous
Previous
Seeking Digital Health Companies for Springboard Health Hub
Next
Next